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ABSTRACT The structures of peptide A, and six other 7–20 amino acid peptides corresponding to sequences in the A region
(Thr671- Leu690) of the skeletal muscle dihydropyridine receptor II-III loop have been examined, and are correlated with the
ability of the peptides to activate or inhibit skeletal ryanodine receptor calcium release channels. The peptides adopted either
random coil or nascent helix-like structures, which depended upon the polarity of the terminal residues as well as the
presence and ionisation state of two glutamate residues. Enhanced activation of Ca2 release from sarcoplasmic reticulum,
and activation of current flow through single ryanodine receptor channels (at40 mV), was seen with peptides containing the
basic residues 681Arg Lys Arg Arg Lys685, and was strongest when the residues were a part of an -helix. Inhibition of
channels (at 40 mV) was also seen with peptides containing the five positively charged residues, but was not enhanced in
helical peptides. These results confirm the hypothesis that activation of ryanodine receptor channels by the II-III loop peptides
requires both the basic residues and their participation in helical structure, and show for the first time that inhibition requires
the basic residues, but is not structure-dependent. These findings imply that activation and inhibition result from peptide
binding to separate sites on the ryanodine receptor.
INTRODUCTION
Contraction in skeletal muscle depends on Ca2 release
from the sarcoplasmic reticulum (SR) through ryanodine
receptor (RyR) calcium release channels. RyRs are acti-
vated during excitation-contraction coupling (ECC) by a
signal originating in the plasmalemmal voltage sensor in the
S4 segment of the 1 subunit of L-type Ca2 channels
(dihydropyridine receptors, DHPRs). The signal initiates a
protein/protein interaction with the RyR via the loop (II-III
loop) between the second and third repeats of the skeletal
DHPR (Tanabe et al., 1990). ECC in skeletal muscle is
independent of external Ca2, and depends only on a correct
interaction between the DHPR and RyR. Ca2-independent
ECC cannot proceed if the DHPR is either absent, or of the
cardiac type (Tanabe et al., 1990; Nakai et al., 1998).
Interaction sites between the DHPR and RyR have been
identified in the A region of the II-III loop between Glu671
and Leu690, which binds to the RyR in surface plasmon
resonance studies (O’Reilly and Ronjat, 1999) and in skel-
etal RyRs between Arg1076 and Asp1112, which binds to the
II-III loop (Leong and Maclennan, 1998). RyRs are acti-
vated by the skeletal DHPR II-III loop and by the 20 amino
acid peptide A (Glu671-Leu690) (Lu et al., 1994, 1995;
El-Hayek et al., 1995; Dulhunty et al., 1999a). Peptide A
activates RyR channels at 40mV, but inhibits at 40mV;
activation is thought to reflect peptide binding to a physio-
logically important DHPR binding site, whereas inhibition
is consistent with peptide binding to negatively charged
groups in the channel pore (Dulhunty et al., 1999a). Al-
though inhibition is unlikely to occur in vivo because the
II-III loop could not reach into the channel pore, the mech-
anism is important because it provides a potential tool for
probing pore structure.
In intact muscle fibers, the peptide A region may facili-
tate binding of the II-III loop to the RyR, whereas other
regions of the II-III loop transmit the ECC signal from the
voltage sensor to the binding region (Dulhunty et al.,
1999a). Thus activation of RyRs by peptide A, or by the
II-III loop, may reflect binding to the RyR rather than
activation equivalent to ECC (Dulhunty et al., 1999a). In-
deed, activation of RyRs by the II-III loop occurs when the
II-III loop has either the cardiac or the skeletal sequence
(Nakai et al., 1998; Lu et al., 1994) and ECC in intact cells
can proceed with a scrambled sequence in the A region
(Proenza et al., 2000). It has been suggested that the highly
charged 680Arg Lys Arg Arg Lys685 region in peptide A is
essential for RyR activation (El-Hayek and Ikemoto, 1998;
Dulhunty et al., 1999b; Zhu et al., 1999).
The structure of the protein/protein interaction sites on
the II-III loop and on the RyR is important for understand-
ing the functional observations and structural changes that
could occur during ECC. We have shown that peptide A is
helical from its N-terminal end to Lys685, but the C-terminal
part is largely unstructured; the last turn of the helix, con-
taining the essential basic residues, is poorly defined (Casa-
rotto et al., 2000). A structural change after Ser687 Ala
substitution extended the -helix further to include the basic
residues, and also enhanced the activation of RyRs by
peptide A (Casarotto et al., 2000). We suggested that the
greater ability of peptide A to activate RyRs after the
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Ser687Ala substitution was due to the increased helical con-
tent of the peptide. An alternative hypothesis that could not
be excluded was that the enhanced activity of the Ser687Ala-
substituted peptide was due to the change in amino acid
character rather than the structural change. Indeed, Ser687
has been shown by others to be important in activation of
RyRs by the II-III loop (Lu et al., 1995). In the present study
we sought to test the hypothesis that activation of RyRs at
40 mV by peptide A requires the 681Arg Lys Arg Arg
Lys685 residues and that activation is greater when the
residues are structured in a helical form. The experiments
also tested the hypotheses that inhibition of RyR activity at
40 mV by peptide A depends on the cluster of positively
charged residues and that activation or inhibition of RyR
channels depend on peptide A binding to different sites on
the RyR. The structural and amino-acid sequence require-
ments of the potentially important inhibition process have
not been previously examined, although it has been sug-
gested that the positively charged residues might be in-
volved in inhibition (Casarotto et al., 2000).
The ability of fragments of peptide A to activate (at 40
mV) or inhibit (40 mV) RyR channels and to release Ca2
from the SR was compared with the presence or absence of
basic amino acids and with the helical content of the pep-
tides (determined by nuclear magnetic resonance (NMR)
and circular dichroism (CD)). Strongest activation was seen
when the basic amino acids were present and had the
greatest helical structure. In contrast, the ability of peptides
to inhibit RyR channels depended only on the presence of
the basic residues and was independent of helical structure.
EXPERIMENTAL PROCEDURES
Peptides
DHPR II-III loop peptides were synthesised as described in
Dulhunty et al. (1999). Peptides used or referred to are:A1:
671Thr Ser Ala Gln Lys Ala Lys Ala Glu Glu Arg Lys Arg
Arg Lys Met Ser Arg Gly Leu690; A2: 671Thr Ser Ala Gln
Lys Ala Lys Ala Glu Glu Arg Lys Arg Arg LysMet Ala Arg
Gly Leu690; A3: 681Arg Lys Arg Arg Lys Met Ser Arg Gly
Leu690; A4: 671Thr Ser Ala Gln Lys Ala Lys Ala Glu
Glu680; A5: 675Lys Ala Lys Ala Glu Glu Arg Lys Arg
Arg684; A6: 678Ala Glu Glu Arg Lys Arg Arg Lys Met
Ser687; A7: 671Thr Ser Ala Gln Lys Ala Lys Ala Glu Glu
Arg Lys Ala Val Ala Met Ser Arg Gly Leu690; and A9:
681Arg Lys Arg Arg Lys Met Ser687.
CD measurements
Precise concentrations of the peptide stocks were deter-
mined (Auspep Propriety, Ltd., Melbourne, Australia) using
acid hydrolysis followed by a standardized phenylthiocar-
bamyl protocol. Samples were diluted to 25 M for CD
measurments, and the pH values adjusted to 3 and 6.5, with
small additions of dilute HCl or NaOH. CD spectra were
collected at 5°C on a Jobin Yvon CD6 Dichrograph (Cedex,
France) using a cell path length of 1 mm. Ten spectra were
collected per sample, averaged and then subjected to a
smoothing function.
NMR spectroscopy
NMR samples were 2 to 3 mM in an H2O solution
containing 10% D2O/90% H2O. 1H chemical shift values
are given relative to 2,2-dimethyl-2-silapentane-5-sulfonate.
The pH conditions for the NMR experiments were carefully
adjusted with microliter additions of dilute (0.5M) 2HCl
or NaO2H. All spectra were acquired on Varian-Inova 600
and 500 spectrometers using spectral widths of 6000 and
5000 Hz, respectively, a pulse width of7 ms (90o), and an
acquisition time of 0.13 s, collecting 2048 data points and
512 increments of 32 transients. Nuclear Overhauser Effect
Spectroscopy (NOESY) (Kumar et al., 1980) and Rotating
Frame Overhauser Effect Spectroscopy (ROESY) (Bothner-
By et al., 1984) spectra with a mixing time of 200 to 500 ms,
Total Correlation Spectroscopy (TOCSY) (Bax and Davis,
1985) spectra with mixing times of 70 ms, and DQF-COSY
(Rance et al., 1983) spectra were acquired at 5°C and used
for the assignment of the 1H-NMR resonances. Suppression
of the H2O resonance for the NOESY and DQF-COSY
spectra was achieved using pulse field gradients (Piotto et
al., 1992; Trimble et al., 1994), whereas water presaturation
was employed for TOCSY and ROESY. The patterns of
backbone hydrogen bonding were assessed by monitoring
the chemical shift of the amide backbone protons with
changes in temperature (4, 12, and 25°C) in TOCSY exper-
iments (Deslauriers and Smith, 1980). The 2D data were
processed on an O2 Silicon graphics work station using the
Felix 95 software package. Data sets were zero-filled to
4096 by 2048 K and multiplied by a phase-shifted sine-bell-
squared function in both dimensions before transformation.
3JNH-H coupling constants were derived from 1D 1H spec-
tra where possible.
Ca2 release from SR
Preparation of SR vesicles, Ca2 release from SR and single
channel techniques have been described (Dulhunty et al.,
1999a). Rabbit skeletal SR vesicles (100 g of protein)
were added to a cuvette, to a final volume of 2 ml of a
solution containing 100 mM KH2PO4 (pH  7), 4mM
MgCl2, 1 mM Na2ATP, and 0.5 mM antipyrylazo III. Ex-
travesicular [Ca2] was monitored at 710 nm. Identical
experiments at 790 nm showed no changes in Optical Den-
sity (OD) that would alter the rate of Ca2 release measured
at 710 nm.
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Single channel techniques
Artificial lipid bilayers of PE, PS, and PC (5:3:2 w/w)
(Avanti Polar Lipids, Alabaster, AL) were painted across a
100-m diameter hole in a delrin cup, separating solutions
containing cis (230 mM CsMS, 20 mM CsCl, 1 mM CaCl2)
or trans (30 mM CsMS, 20 mM CsCl, 1 mM CaCl2); both
with 10 mM [ TES (pH 7.4) with CsOH] (Dulhunty et al.,
1999a; Casarotto et al., 2000). For recording, (a) the cis
solution was replaced with an identical solution, but with
104 M Ca2, and (b) 200 mM CsMS was added to the
trans chamber. Channel activity was recorded, and mean
current (I) measured, over a range of peptide concentra-
tions at40 mV and40 mV. Potential was changed every
30 s and activity recorded for 2 min under each condition.
Potential is expressed as Vcis  Vtrans (or Vcytoplasm 
Vlumen). SR vesicles and peptides were added to the cis
chamber at 20 to 25°C. Average data is given as mean 
SEM.
RESULTS
NMR studies of peptides
Complete 1H assignments for peptides A4, A5, and A6 (at
pH 3 and 5) and peptides A3 and A9 (at pH 3) are presented
in Table 1 along with 3JNH-H coupling constants. These
assignments were made using standard 2D methods, i.e., 2D
TOCSY experiments to identify spin types and NOESY
experiments to make sequence specific assignments. The
amide region of the NOESY spectra for peptides A4, A5,
and A6 are shown at pH 3 and 5 (Fig. 1). Backbone
NHi-NHi1 NOE cross-peaks are visible for peptides A4,
A5, and A6 at both pH values. At pH 3, peptide A4 shows
weak NHi-NHi1 cross-peaks throughout the entire peptide
chain, but shows a marked decrease in the number of NOEs
at pH 5. The converse is true for peptide A6, where weak
NHi-NHi1 NOEs are evident at pH 5, but absent at pH 3.
The pH 3 and pH 5 spectra for peptide A5 shows only a few,
relatively weak, cross-peaks, compared with either A4 or
A6. No NHi-NHi1 cross-peaks occurred for A3 or A9 in
either ROESY or NOESY spectra (not shown).
Secondary structural information can also be derived
from the 3JNH-H coupling constants, -proton chemical
shift index (CSI) and hydrogen bonding information sum-
marized in Fig. 2. Peptide A6 at pH 5 shows the greatest
evidence of helical structure in that all NMR parameters
strongly point to a helical conformation. For example, cou-
pling constants for A6 were  6 Hz, the temperature coef-
ficients greater than 4.0 ppb (for the majority of the
residues), and an upfield shift of the  protons are all
compatible with a helix-type structure. Peptides A4 and A5
show some coupling-constant and temperature coefficient
data, indicating potential helical character, but this is not
seen in the CSI data. Peptides A3 and A9 do not show any
of these characteristic helical traits, suggesting that both of
these peptides adopt random coil structures in solution.
These NMR results imply that, of the peptides studied, it is
peptide A6 which exhibits the greatest helical content at pH
5; A4 and A5 show a small amount of helical structure and
peptides A3 and A9 exhibit random coil structures.
Circular dichroism
CD spectra of peptides A1, A2, A4, A5, and A6 are shown
at high (6.5) and low (3.0) pH to illustrate effects of proto-
nation of glutamate residues, whereas traces for A3 and A9
(which lack glutamates) are shown only at high pH (Fig. 3).
As expected from previous NMR results (Casarotto et al.,
2000), A1 and A2 show profiles that are characteristically
associated with helical-type structures. The greater mini-
mum at 222 nm suggests that A2 is slightly more helical in
structure than A1. The minimum at 200 nm for A1 is
significantly affected by a change in pH, whereas only a
modest difference is seen in A2, indicating that ionisation of
the glutamate residues plays a more significant role in
stabilising the helix in A1 than in the A2 peptide. Both of
these peptides also exhibit a positive band at 185 nm,
which is more prominent at higher pH values. A positive
185 nm region is also present for peptide A6, as is a
minimum at 200 nm. A clear spectral change at these
wavelengths is observed with A6 when pH is lowered to
3.0, as is a slight reduction of the minimum at222 nm. All
these changes indicate that the ionisation state of the gluta-
mate residues act to stabilise the helix. Peptides A4, A5 A3
and A9 do not show a positive band at 185 nm and have
minimums that range from 195–197 nm. Only a modest
shift in the minimum at 197 nm is observed for A5 with a
change in pH, whereas the direction of the shift for A4 (2
nm) is in the opposite direction to that seen with peptides
A1, A2, and A6. No minimums are seen for peptides A4, A5
A3 and A9 at 222 nm, although a slight dip is seen for
peptide A4 at low pH. This data indicates a helical order at
high pH of A2	A1	A6	A4	A5	A3  A9.
Ca2 release from SR vesicles
SR vesicles were partially loaded with Ca2 (Dulhunty et
al., 1999a). Thapsigargin (200 nM) was then added to block
Ca2 uptake by the SR Ca2, Mg2-ATPase (first arrow in
each inset Fig. 4) after which extravesicular Ca2 increased
slowly, due to Ca2 leakage through RyRs. Peptide was
added for 3 min (second arrow). 5 M cis ruthenium red
(third arrow) then prevented further increases in extravesi-
clular Ca2, showing that the increase in [Ca2] was due to
Ca2 release through RyR channels. The Ca2 ionophore
A23187 (3 g/ml), added at the fourth arrow, released the
remaining Ca2, confirming that Ca2 was available for
release.
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TABLE 1 Proton assignment for the A3, A4, A5, A6, and A9 peptide in 10%/90% D2O/H2O at 5°C
Residue NH H H Other J(NH-H) (Hz)
Peptide A3, pH 5
Arg-681 8.50 4.31 1.82/1.75 H 1.63/1.63, H 3.21/3.21
Lys-682 8.56 4.31 1.81/1.74 H 1.46/1.40, H 1.66/1.66, H 2.99
Arg-683 8.45 4.23 1.80/1.75 H 1.66/1.66, H 3.21/3.21 6.4
Arg-684 8.55 4.30 1.76 H 1.63/1.63, H 3.21/3.21
Lys-685 8.61 4.27 1.76/1.68 H 1.46/1.40, H 1.68/1.68, H 2.99
Met-686 8.66 4.55 2.01/2.09 H 2.55/2.62, H 2.00
Ser-687 8.50 4.47 3.87/3.87
Arg-688 8.63 4.37 1.89/1.80 H 1.67/1.67, H 3.22/3.22
Gly-689 8.56 3.95
Leu-690 8.37 4.30 1.67/1.67 H 1.6, H 0.88/0.93 7.4
Peptide A4, pH 3
Thr-671 8.37 4.34 4.20 H 1.23
Ser-672 8.63 4.39 3.90/3.90 6.2
Ala-673 8.46 4.27 1.39 5.7
Gln-674 8.28 4.20 2.06/2.06 H 2.39/2.39 6.6
Lys-675 8.37 4.21 1.83/1.76 H 1.43/1.48, H 1.66, H 2.96/2.96
Ala-676 8.31 4.23 1.39
Lys-677 8.25 4.19 1.84/1.77 H 1.45/1.45, H 1.68, H 3.00/3.00 6.4
Ala-678 8.31 4.23 1.39
Glu-679 8.33 4.32 2.02/2.14 H 2.52/2.52
Glu-680 8.30 4.30 2.00/2.12 H 2.48/2.48
Peptide A4, pH 5
Thr-671 8.36 4.35 4.23 H 1.23
Ser-672 8.59 4.42 3.89/3.89 6.2
Ala-673 8.47 4.29 1.40
Gln-674 8.33 4.23 2.07/2.00 H 2.38/2.38 6.7
Lys-675 8.41 4.24 1.83/1.76 H 1.47/1.47, H 1.67, H 3.00/3.00
Ala-676 8.41 4.24 1.39
Lys-677 8.36 4.25 1.83/1.77 H 1.45/1.45, H 1.68, H 2.99/2.99
Ala-678 8.46 4.27 1.39 6.5
Glu-679 8.49 4.27 2.08/1.96 H 2.34/2.34
Glu-680 8.42 4.24 2.08/1.98 H 2.33/2.33
Peptide A5, pH 3
Lys-675 8.42 4.20 1.81/1.76 H 1.44/1.35, H 3.00
Ala-676 8.50 4.27 1.38
Lys-677 8.35 4.21 1.81/1.75 H 1.43, H 1.67, H 3.00 6.2
Ala-678 8.37 4.25 1.39
Glu-679 8.44 4.28 2.07/1.99 H 2.44/2.44
Glu-680 8.41 4.27 2.00 H 2.41/2.41
Arg-681 8.47 4.27 1.84/1.77 H 1.61, H 3.19 7.8
Lys-682 8.37 4.25 1.82/1.76 H 1.47, H 1.69, H 3.00 6.0
Arg-683 8.42 4.27 1.79 H 1.60, H 3.19
Arg-684 8.49 4.28 1.85/1.73 H 1.69, H 3.20
Peptide A5, pH 5
Lys-675 8.42 4.19 1.80/1.74 H 1.47, H 1.66, H 3.00
Ala-676 8.52 4.27 1.40
Lys-677 8.37 4.21 1.81/1.77 H 1.49/1.45, H 1.68, H 3.00
Ala-678 8.41 4.23 1.41
Glu-679 8.51 4.20 2.05 H 2.41/2.34
Glu-680 8.42 4.19 2.07 H 2.41/2.34
Arg-681 8.37 4.26 1.81/1.77 H 1.68/1.62
Lys-682 8.28 4.24 1.85/1.78 H 1.49/1.39, H 1.66, H 2.98 6.8
Arg-683 8.39 4.27 1.87/1.79 H 1.70/1.63, H 3.21
Arg-684 8.39 4.27 1.87/1.79 H 1.70/1.63, H 3.21
(continued)
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Average rates of peptide-enhanced Ca2 release (the rate
with peptide minus that with thapsigargin) are shown Fig. 4.
The solid lines show average data for A1 (Dulhunty et al.,
1999a), which we included for comparison. The insets show
OD changes obtained with each peptide. A3, containing the
basic 681Arg Lys Arg Arg Lys685 sequence but lacking
helical structure (above), caused a small increase in the rate
of Ca2 release at 5 M to 15 M (Fig. 4 A), but rates
fell with higher concentrations. Peptide A4, lacking the five
consecutive basic residues, but having some helical struc-
tural characteristics did not increase the rate of Ca2 release
(Fig. 4 B). Peptide A5, with four of the five basic residues,
but little helical structure, evoked Ca2 release (Fig. 4 C),
but at a substantially lower rate than A6 (Fig. 4 D). A6
contained all five basic residues and had some structure.
There was little increase in Ca2 release with A7 (contain-
ing only two of the five basic residues); (Fig. 4 E) or with
A9 (which, like A3, had all five basic residues but no helical
structure) (Fig. 4 F). Data for A9 taken from Casarotto et
al., 2000 (broken line in Fig. 4 F) is included for compar-
ison. The order of peptides in releasing Ca2 from SR was
A6A1	A3	A5	A4  A7  A9.
Single RyR channel activity
The activity of single RyR channels, with 104 M cis Ca2
with 2 mM cisMgATP, at 40 mV increases when peptide
A (at concentrations between 100 nM and 50 M) is added
to the cis chamber, but is blocked at 40 mV (with peptide
concentrations greater than 1 M, (Dulhunty et al., 1999a).
Single RyR channel activity in this study was also recorded
at40 mV and40 mV, with 100 M cis Ca2 and 2 mM
cis MgATP, to compare short peptide activity with peptide
A activity. Potentials of40 mV and40 mV were used to
separate the activating and inhibiting effects of the peptide
and to compare each effect with peptide structure. A cis
Ca2 concentration of 100 M was used because inhibition
at40 mV is most obvious with 100 M cis Ca2, whereas
activation is apparent over a range of cis Ca2 from 100 nM
to 10 M (Dulhunty et al., 1999a).
The records in Fig. 5 show an increase in channel activity
with A5 and A6 (40 mV) and a decrease in channel
activity with A3, A5, and A7 (40 mV). Average normal-
ized mean current (Ip/Ic, defined in the legend to Fig. 6) is
also shown at 40 mV and 40 mV (Fig. 6). Published
data for the native sequence (peptide A1) and peptide A9
TABLE 1 (Continued)
Residue NH H H Other J(NH-H) (Hz)
Peptide A6, pH 3
Ala-678 8.51 4.15 1.39 4.7
Glu-679 8.64 4.26 2.01/2.08 H 2.46/2.46 5.9
Glu-680 8.34 4.25 2.02/2.08 H 2.46/2.46 5.9
Arg-681 8.28 4.22 1.83/1.83 H 1.58/1.71, H 3.18/3.23 6.5
Lys-682 8.24 4.24 1.78/1.85 H 1.40/1.49, H 1.67/1.67, H 2.99/2.99 6.4
Arg-683 8.31 4.27 1.78/1.86 H 1.63/1.71, H 3.20/3.20 6.3
Arg-684 8.40 4.27 1.79/1.84 H 1.64/1.64, H 3.20/3.20 6.6
Lys-685 8.48 4.27 1.78/1.85 H 1.44/1.48, H 1.70/1.70, H 3.00/3.00 6.5
Met-686 8.60 4.53 2.03/2.16 H 2.56/2.65 6.9
Ser-687 8.36 4.42 3.89/3.89 7.1
Peptide A6, pH 5
Ala-678 8.56 4.12 1.40 4.3
Glu-679 8.73 4.16 1.99/2.04 H 2.31/2.31 5.7
Glu-680 8.40 4.15 2.00/2.04 H 2.33/2.33 5.8
Arg-681 8.20 4.14 1.84/1.71 H 1.60/1.60, H 3.25/3.17 5.4
Lys-682 8.06 4.19 1.89/1.83 H 1.51/1.40, H 1.69/1.69, H 2.96/2.96 5.9
Arg-683 8.13 4.21 1.85/1.71 H 1.62/1.62, H 3.20/3.20 6.6
Arg-684 8.26 4.23 1.83/1.71 H 1.64/1.64, H 3.19/3.19 5.3
Lys-685 8.34 4.26 1.88/1.81 H 1.48/1.38, H 1.69/1.69, H 3.00/3.00 5.9
Met-686 8.49 4.50 2.04/2.04 H 2.67/2.57, H 2.17 6.7
Ser-687 8.30 4.41 3.89/3.89 6.8
Peptide A9
Arg-681 8.47 4.23 1.72/1.89 H 1.36/1.54, H 3.14 6.3
Lys-682 8.59 4.31 1.82 H 1.44, H 1.55, H 2.99
Arg-683* 8.53 4.31 1.74/1.86 H 1.42/1.59, H 3.14 7.0
Arg-684* 8.57 4.29 1.78 H 1.60/1.43, H 3.14
Lys-685 8.64 4.28 1.82/1.88 H 1.37/1.47, H 1.58, H 2.99 6.8
Met-686 8.74 4.57 2.01/2.16 H 2.66/2.55 7.2
Ser-687 8.44 4.43 3.87/3.87 7.0
*Could not be definitively assigned due to ambiguity.
Several coupling constants are not listed due to peak overlap.
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(Dulhunty et al., 1999a) are included for comparison (small
symbols, continuous lines in Fig. 6 A–E, and broken lines,
Fig. 6 E respectively). The effects of the peptides on chan-
nel kinetics are shown in Fig. 7. Kinetic results are shown as
nPo, nTo, nFo, and nTc so that data from many bilayers
containing two channels (which often became apparent after
peptide activation) could be included. It should be noted that
bilayers containing only one channel showed the same
relative changes in kinetics as bilayers containing two chan-
nels. Ruthenium red was added at the end of each experi-
ment and abolished activity in all cases.
A3 and A5 caused small increases in channel activity at
40mV; both peptides contained the full basic sequence,
but lacked helical structure. A greater twofold increase in
I’p/I’c occurred with A6, which contained the five basic
residues and was moderately structured. The increase in
mean current was associated with significant increases in
nPo and nTo (Fig. 7, 40mV). In contrast A4 which lacked
the five sequential basic residues did not alter RyR activity.
There was very little increase in mean current or nPo with
A7 (analysis data not included in Fig. 7) or A9. There was
no change in single channel conductance with any of the
peptides at 40mV. The order of the peptides in activating
RyRs was A1	A6	A5	A3	A7  A9  A4.
Inhibition, a fall in channel activity at 40mV, was
seen with A3, A5, A6, and A9, but not with A4 (Figs.
5–7). Inhibition by peptide A was characterized by re-
ductions in the frequency, duration and amplitude of
channel opening (Dulhunty et al., 1999a) and the same
changes were seen with the short peptides (Fig. 7). Sig-
nificant reductions in nPo, nTo and nFo, and an increase
in nTc, were seen with A3, A6, and A9. No significant
changes were seen with A7 (data not included). Curi-
ously, an inhibiting decrease in nPo and nTo with A9 was
seen at both 40mV and 40mV. The order of peptides
in inhibiting RyRs was A3	A9	A1  A6	A5	A7 
A4. Therefore, in contrast to activation, strongest inhibi-
tion was seen with peptides which contained 681Arg Lys
Arg Arg Lys685, but not necessarily in a structured con-
formation.
DISCUSSION
This report examines the structure/function relationships of
peptides corresponding to the peptide A region of the II-III
loop of the skeletal DHPR 1 subunit. We previously found
that increasing the helical content of the C-terminal end of
peptide A, by a Ser687 to Ala substitution increased the
ability of the peptide to activate skeletal RyRs and we
suggested that the greater helical structure may be respon-
sible for enhanced RyR activation (Dulhunty et al., 1999a;
FIGURE 1 Amide-amide region of the NOESY spectra of peptides A4, A5, A6 at pH 3 and 5. Connected i-i1 NOEs are shown and correspondingly
labeled (residue 1 corresponds to the N-terminal residue) in the spectra.
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Casarotto et al., 2000). This hypothesis has been explored in
the present study, in which we constructed different pep-
tides fragments in order to examine the influence of the five
basic residues (681Arg Lys Arg Arg Lys685) on activity and
helical structure.
Structural observations
Although short peptides are most likely to adopt a random
coil structure, both NMR and CD spectra suggested that
some of the short peptides examined here tend to adopt a
nascent helix-type conformation (i.e., an interconverting
mixture of random coil and structured peptide). This asser-
tion is based on the presence of NOEs between amide to
amide protons (NHi-NHi1), indicating an -helix, but the
absence of weaker NOEs synonymous with helical structure
(i.e., NHi-NHi2,Hi -NHi3, or Hi -Hi3). Other NMR
parameters such as 3JNH-H coupling constants, -proton
chemical shift index (CSI1), and hydrogen bonding data also
support a helical-like structure. The CD profile for an ideal
FIGURE 2 Summary of the sequential NHi-NHi1 NOE connectivities, 3JNH-H coupling constants, -proton chemical shift index (CSI1) and temperature
coefficients at 5°C in 10%/90% D2O/H2O for peptides A3, A9 (pH 3) and A4, A5, A6, and A9 (pH 3 and 5). The NOE connectivities are indicated by
horizontal black lines with thickness proportional to NOE intensity. Values of 3JNH-H 	6 Hz are indicated by 2. Temperature coefficients 	4.0 ppb
are represented by closed circles. The CSI shows the H chemical shift of residues which deviate from random coil values (Wishart et al., 1991).
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helix exhibits a positive band at 190 nm, and minimums at
208 and 222 nm (Woody and Tinco, 1967). Some peptides
showed minimums near 200 and 222 nm, as well as a
positive band near 185 nm. Such profiles represent devia-
tions from the ideal profile, supporting the concept of a
mixture of helix and random coil structure. The NMR and
CD indicators, when combined, form a compelling argu-
ment for the presence structures which contain helix-like
characteristics for some of the peptides. Because of the lack
of well defined helices, the solution structures of the pep-
tides were not accurately determined. However, a qualita-
tive assessment of the level of helical content can be made.
High resolution solution structures of peptides A1 and A2
from NMR (Casarotto et al., 2000) show a greater helical
content for A2 than A1, which is confirmed here by the
more pronounced CD minimum at 222 nm, and a greater
positive region at 185 nm observed in A2 compared to A1.
The effects of pH on the spectra for the two peptides reveals
that the glutamate residues aid in stabilization of the helix at
high pH, via side chain interactions between the glutamate
and arginine/lysine residues. The irregular helical structure
of A1 is more susceptible than the more regular helical
conformation of A2 to removal of the side chain-side chain
FIGURE 3 CD spectra at 5°C of solutions of peptide A3, A4, A5, A6,
and A9 (concentrations of 2.5 
 105 M). Solid lines denote spectra
acquired at pH 6.5 and broken lines at pH 3.0. Both spectra for A3 and A9
were acquired at pH 6.5. The thin line is for A3 and the thick line for A9.
Vertical dotted lines are drawn at 200-nm and 222-nm. The peptide
structure is indicated by the bars above each set of records. The thin bar
shows the full length peptide A, medium bar shows the position and length
of each particular peptide and the short bar indicates the position and
number of positively charged residues from the 681Arg Lys Arg Arg Lys685
sequence.
FIGURE 4 Effect of peptides on Ca2 release from SR. (A-F) show
initial rates of Ca2 release (nmol/mg of TC vesicles/min) induced by
peptides, i.e., the initial rate with peptide, minus the preceding rate with
thapsigargin. The large circles are means SEM (n 3, three different SR
preparations). Small filled circles (continuous lines) show average data for
the native A1 (Dulhunty et al., 1999a) and the small open circles in (F)
(dashed lines) show average data for peptide A9 (Casarotto et al., 2000),
both included for comparison. The insets are records of OD changes at 710
nm. The first arrow indicates addition of 200nM thapsigargin and the
second addition of (in M): (A) 5, A3; (B) 30, A4; (C) 60, A5; (D) 60 A6;
(D) 60 A7 and (F) 60 A9. Ruthenium red (10 M) was added at third
arrow, before the ionophore A23187 (last arrow, 3 g/ml). The vertical
calibration is 0.1 OD unit [addition of 10 M Ca2 (or 20 nmoles)
increased OD by 0.1 unit]. The horizontal calibration is 1 min. The peptide
segment of A is indicated by the bars above each set of records (described
in the legend to Fig. 3).
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interactions at pH 3. This suggests that A1 relies much more
than A2 on the side chain-side chain interactions to maintain
its helical integrity.
Apart from A1 and A2, one other peptide with sub-
stantial helical content was A6 at pH above the pKa value
of the glutamate residues. The helical nature of A6 at
high pH is indicated by a complete set of NHi-NHi1
NOEs, 3JNH-H coupling constants, -proton chemical
shift index (CSI), and hydrogen bonding, whereas a pos-
itive band at 185 nm, minimum at 200 nm, and a
slight minimum at 222 nm are apparent in the CD
spectrum. The loss of the helix-indicating NMR param-
eters at low pH, the disappearance of the positive 185 nm
band, and the shift in CD minimums at 199 nm to lower
wavelengths (197 nm) show that protonation of the
glutamates does play a helix stabilizing role. A similar
feature was observed for peptides A1 and A2, in which
the negatively charged glutamate and lysine/arginine res-
idues (681–685) were found to stabilize the helix (Casa-
rotto et al., 2000).
Compared to peptide A6, the opposite effect was seen
for A4, in which evidence of a modest amount of helical
character was observed for A4 at low pH but not at high
pH. Indeed, the presence of NHi-NHi1 NOEs in the
NOESY experiment at low pH suggests that all A4 res-
idues participate in the formation of a respectable -he-
lix. This fact is supported not only by NOE evidence, but
by CD minimum at 198 nm and the shallow, broad
minimum at 222 nm at pH 3. The helical component was
diminished at high pH, indicated by loss of NMR helical
indicators and a shift in the CD spectrum minimum from
198 to197 nm. This may be due to destabilization of the
helix by unfavorable interactions between the negative
side chains of the ionized terminal glutamate residues
(pH 	4), and the natural negative dipole of the C-
terminal end of the helix (Vieille and Zeikus, 1999). This
interaction is removed upon protonation of the glutamate
side chains at pH 3.
Peptide A5 shows little if any structure at high or low
pH, and A3 and A9 were unstructured. The lack of
structure of A5 was surprising since it contained both
glutamate and arginine/lysine residues, but may be ex-
plained by destabilizing interactions between the natural
dipole of the helix and the basic residues at the N-
terminus of the peptide disrupting the Glu/Lys-Arg in-
teractions. Similar destabilizing interactions would occur
in the unstructured A3 and A9 peptides that, in conjunc-
tion with the absence of glutamate residues, would lower
the probability of helix formation.
These findings show that of the short peptides, it is A6
at high pH which displays the greatest structural charac-
teristics which are consistent with an -helix. This, in
part, is due to the amino acid composition; particularly
the stabilizing effect of the charged residues at either end
of the helix and the ionic involvement of the acidic
glutamate residues with the basic residues in the se-
quence. The tendency of these shorter peptides to form
-helices at high pH can be summarized as follows:
A6	A4	A5	A3  A9.
Activation of Ca2 release and RyR channels
at 40mV
Our results confirm previous studies which suggested
that the five basic residues (681Arg Lys Arg Arg Lys685)
are necessary for RyR activation by peptide A (El-Hayek
and Ikemoto, 1998; Dulhunty et al., 1999b; Zhu et al.,
FIGURE 5 Single channel activity at
40mV and 40mV, before (control)
and after (6 M peptide) addition of 6
M peptide to the cis solution bathing
bilayers containing RyR channels. The
mean current from a 30 s recording is
shown at the top right hand corner of
each record. Peptides added were A3
(A), A4 (B), A5 (C) and A6 (D). The
continuous line in each record shows the
closed channel current (labeled C). The
broken line shows the maximum open
channel conductance (labeled O).
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1999). Peptide A4, which lacks the residues, was inac-
tive, whereas A3, which contains the residues, showed
activity. However, in contrast to El Hayek and Ikemoto
(El-Hayek and Ikemoto, 1998), we found that the C-
terminal half of peptide A (A3) (equivalent to AS10) is
both a poor activator of RyR channels and is not very
effective in releasing Ca2 from SR vesicles. The differ-
ences may lie in the different techniques used. The
previous studies examined tritiated ryanodine binding
rather than single RyR channel activity and used a
faster spectrophotometric technique than that used in our
studies.
The low activity of A3 here, in conjunction with the
unstructured nature of the peptide, is consistent with trends
seen with the other peptides, and is also consistent with the
hypothesis that the ability of peptides to bind to the RyR and
increase its activity depends on a helical structure. The
increase in Ca2 release from the SR, and in channel
activity at 40 mV with low [A3] could be because shorter
unstructured peptide can more easily approach the binding
pocket of RyRs in SR vesicles, but once there, binds less
effectively.
Block of channel activity
A fall in RyR activity at40 mV is seen with peptide A at	1
M, and is thought to be due to peptide action at a second site
on the RyR because its characteristics differ from those of
activation at 40 mV. Reduced channel conductance during
the inhibition, its voltage-dependence and its sensitivity to the
direction of current flow are consistent with the peptide enter-
ing and blocking the channel pore, as positively charged
groups on the peptide bind to negatively charged groups in the
vestibule (Dulhunty et al., 1999a).
We show here that inhibition indeed depends on the positive
charge density in the peptide. No inhibition was seen with A4,
although it contains two lysine residues, or with A7, which
contained two of the five sequential basic residues. Some
inhibition was seen with A5, having four of the five residues,
and stronger inhibition seen with A1 and A6 (containing the
five residues in a structured conformation). Strongest inhibi-
tion was seen with the unstructured A3 and A9, perhaps
because the five positively charged residues were free to form
multiple random associations with scattered negative charge
near the pore (Mead et al., 1998). The fact that inhibition was
greatest when the basic residues were unstructured provides
further evidence that activation and inhibition result from pep-
tide binding to different sites. Activation is likely to depend on
specific binding of the peptide to a pocket in the RyR that is
designed to accept positively charged residues in a helical
structure.
In summary, we show here that, by controlling the
composition of peptides derived from the DHPR II-III
loop to include residues (681Arg Lys Arg Arg Lys685), we
are able to influence the level of helical structure im-
parted on the peptide. This is best illustrated in peptides
A1, A2 and A6 where helical content is controlled by the
amino acid composition of these peptides. Key amino
acid features for these three peptides were found to
include strategically important glutamate and arginine/
lysine residues as well as helix dipole stabilizing resi-
FIGURE 6 Effects of peptides on relative mean current flowing through
RyRs at 40 mV and 40 mV. (A–E), relative mean current (Ip/Ic, see
text) is plotted against the logarithm of [peptide A] in nM. Symbols show
average Ip/Ic and vertical bars show 1 SEM where this is greater than
the dimensions of the symbol. 100 M Ca2 and 2mM MgATP were
present in cis solution: (A)A3 (n 6); (B)A4, (n 5); (C)A5 (n
8); (D) A6, (n  15); (E), A7, (n  8). The small filled circles
(continuous lines) show average data for A1 (Dulhunty et al., 1999a) and
small open circles in (E) (dashed lines) show average data for A9 (Casa-
rotto et al., 2000), both included for comparison. The records above each
graph give data shown in Fig. 6 and are included for comparison. The
peptide segment of A is indicated by the bars above each set of records
(described in the legend to Fig. 3).
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dues at the terminal ends. The helical structure of the
basic residues (681Arg Lys Arg Arg Lys685), in turn,
controls the amount of activation of Ca2 release from
the SR and amount of RyR regulation. In addition we
found that inhibition by peptide A at 40 mV depends on
the presence of these five basic residues, and that it is
greatest when peptides (A3 and A9) have the least struc-
ture.
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